What is rubitin/rubicatin (Zanbiga) and its clinical application analysis

Lurbinectedin (Lurbinectedin), also known as rubicatin, is a new type of anti-tumor targeted drug that is a DNA binding inhibitor. Its main mechanism of action is to inhibit the transcriptional activity of tumor cells by binding to DNA and interfere with the RNA synthesis of cancer cells, thereby inducing apoptosis of cancer cells. Compared with traditional chemotherapy drugs, rubitidine has higher selectivity and less damage to normal cells, so it has shown better tolerability and safety in clinical practice.

In terms of clinical application, rubitidine is mainly used for the treatment of small cell lung cancer (SCLC), especially for patients who have relapsed after previously receiving platinum-based chemotherapy. Clinical trial data show that the drug can significantly prolong progression-free survival (PFS) and overall survival (OS) in patients with recurrent small cell lung cancer, and improve the objective response rate (ORR) of some patients. Therefore, rubitidine provides a new and effective treatment option for patients who fail conventional chemotherapy.

Rubitin is usually administered by intravenous infusion, usually every 3 weeks. Doctors will adjust the dose based on the patient's body surface area, liver function status, and previous treatments. Since it is mainly metabolized by the liver, patients with abnormal liver function need to be evaluated before taking the drug, and the dose may need to be adjusted or the dosing interval extended to ensure drug safety.

In terms of safety and precautions, possible side effects of rubitidine include bone marrow suppression (such as neutropenia), fatigue, nausea, vomiting, and increased liver function indicators. Most adverse reactions can be controlled through dose adjustment, symptomatic treatment, or short-term discontinuation. In addition, patients using rubitidine should regularly review blood routine and liver function indicators, and closely observe the efficacy and tolerance to ensure the safety and effectiveness of the treatment.

Reference materials:https://www.drugs.com/